212 related articles for article (PubMed ID: 20143441)
1. Racial and insurance disparities in the receipt of transplant among patients with hepatocellular carcinoma.
Yu JC; Neugut AI; Wang S; Jacobson JS; Ferrante L; Khungar V; Lim E; Hershman DL; Brown RS; Siegel AB
Cancer; 2010 Apr; 116(7):1801-9. PubMed ID: 20143441
[TBL] [Abstract][Full Text] [Related]
2. Racial disparities in utilization of liver transplantation for hepatocellular carcinoma in the United States, 1998-2002.
Siegel AB; McBride RB; El-Serag HB; Hershman DL; Brown RS; Renz JF; Emond J; Neugut AI
Am J Gastroenterol; 2008 Jan; 103(1):120-7. PubMed ID: 18005365
[TBL] [Abstract][Full Text] [Related]
3. Racial and Ethnic Differences in Presentation and Outcomes of Hepatocellular Carcinoma.
Rich NE; Hester C; Odewole M; Murphy CC; Parikh ND; Marrero JA; Yopp AC; Singal AG
Clin Gastroenterol Hepatol; 2019 Feb; 17(3):551-559.e1. PubMed ID: 29859983
[TBL] [Abstract][Full Text] [Related]
4. Racial/ethnic disparities in access to care and survival for patients with early-stage hepatocellular carcinoma.
Mathur AK; Osborne NH; Lynch RJ; Ghaferi AA; Dimick JB; Sonnenday CJ
Arch Surg; 2010 Dec; 145(12):1158-63. PubMed ID: 21173289
[TBL] [Abstract][Full Text] [Related]
5. Persistent disparities in liver transplantation for patients with hepatocellular carcinoma in the United States, 1998 through 2007.
Robbins AS; Cox DD; Johnson LB; Ward EM
Cancer; 2011 Oct; 117(19):4531-9. PubMed ID: 21448933
[TBL] [Abstract][Full Text] [Related]
6. Medicaid and Uninsured Hepatocellular Carcinoma Patients Have More Advanced Tumor Stage and Are Less Likely to Receive Treatment.
Wang J; Ha J; Lopez A; Bhuket T; Liu B; Wong RJ
J Clin Gastroenterol; 2018; 52(5):437-443. PubMed ID: 28723861
[TBL] [Abstract][Full Text] [Related]
7. Race, ethnicity, and socioeconomic status influence the survival of patients with hepatocellular carcinoma in the United States.
Artinyan A; Mailey B; Sanchez-Luege N; Khalili J; Sun CL; Bhatia S; Wagman LD; Nissen N; Colquhoun SD; Kim J
Cancer; 2010 Mar; 116(5):1367-77. PubMed ID: 20101732
[TBL] [Abstract][Full Text] [Related]
8. Disentangling the effects of race and socioeconomic factors on liver transplantation rates for hepatocellular carcinoma.
Sarpel U; Suprun M; Sofianou A; Berger Y; Tedjasukmana A; Sekendiz Z; Bagiella E; Schwartz ME
Clin Transplant; 2016 Jun; 30(6):714-21. PubMed ID: 27027869
[TBL] [Abstract][Full Text] [Related]
9. Racial/ethnic disparities in hepatocellular carcinoma treatment and survival in California, 1988-2012.
Stewart SL; Kwong SL; Bowlus CL; Nguyen TT; Maxwell AE; Bastani R; Chak EW; Chen MS
World J Gastroenterol; 2016 Oct; 22(38):8584-8595. PubMed ID: 27784971
[TBL] [Abstract][Full Text] [Related]
10. Racial Disparity in Liver Transplantation Listing.
Warren C; Carpenter AM; Neal D; Andreoni K; Sarosi G; Zarrinpar A
J Am Coll Surg; 2021 Apr; 232(4):526-534. PubMed ID: 33444709
[TBL] [Abstract][Full Text] [Related]
11. African-American patients are less likely to receive drug-eluting stents during percutaneous coronary intervention.
Gaglia MA; Shavelle DM; Tun H; Bhatt J; Mehra A; Matthews RV; Clavijo L
Cardiovasc Revasc Med; 2014 Jun; 15(4):214-8. PubMed ID: 24814420
[TBL] [Abstract][Full Text] [Related]
12. Association Between Race/Ethnicity and Insurance Status with Outcomes in Patients with Hepatocellular Carcinoma.
Scaglione S; Adams W; Caines A; Devlin P; Mittal S; Singal AG; Parikh ND
Dig Dis Sci; 2020 Jun; 65(6):1669-1678. PubMed ID: 31643036
[TBL] [Abstract][Full Text] [Related]
13. Race/Ethnicity-specific Disparities in Hepatocellular Carcinoma Stage at Diagnosis and its Impact on Receipt of Curative Therapies.
Ha J; Yan M; Aguilar M; Tana M; Liu B; Frenette CT; Bhuket T; Wong RJ
J Clin Gastroenterol; 2016; 50(5):423-30. PubMed ID: 26583267
[TBL] [Abstract][Full Text] [Related]
14. Disparities in Access to Liver Transplant Referral and Evaluation among Patients with Hepatocellular Carcinoma in Georgia.
Ross-Driscoll K; Ayuk-Arrey AT; Lynch R; McCullough LE; Roccaro G; Nephew L; Hundley J; Rubin RA; Patzer R
Cancer Res Commun; 2024 Apr; 4(4):1111-1119. PubMed ID: 38517133
[TBL] [Abstract][Full Text] [Related]
15. Association of socioeconomics, surgical therapy, and survival of early stage hepatocellular carcinoma.
Peters NA; Javed AA; He J; Wolfgang CL; Weiss MJ
J Surg Res; 2017 Apr; 210():253-260. PubMed ID: 28457336
[TBL] [Abstract][Full Text] [Related]
16. Comparison of Liver Transplant Wait-List Outcomes Among Patients With Hepatocellular Carcinoma With Public vs Private Medical Insurance.
Gutin L; Yao F; Dodge JL; Grab J; Mehta N
JAMA Netw Open; 2019 Aug; 2(8):e1910326. PubMed ID: 31469395
[TBL] [Abstract][Full Text] [Related]
17. Prostate cancer outcomes for men aged younger than 65 years with Medicaid versus private insurance.
Mahal AR; Mahal BA; Nguyen PL; Yu JB
Cancer; 2018 Feb; 124(4):752-759. PubMed ID: 29084350
[TBL] [Abstract][Full Text] [Related]
18. The Impact of Race on Survival After Hepatocellular Carcinoma in a Diverse American Population.
Jones PD; Diaz C; Wang D; Gonzalez-Diaz J; Martin P; Kobetz E
Dig Dis Sci; 2018 Feb; 63(2):515-528. PubMed ID: 29275448
[TBL] [Abstract][Full Text] [Related]
19. Race and Insurance Status as Predictors of Bicycle Trauma Outcome in Adults.
Chen H; Scarborough J; Zens T; Brummeyer B; Agarwal S; Haines KL
J Surg Res; 2020 Jan; 245():198-204. PubMed ID: 31421362
[TBL] [Abstract][Full Text] [Related]
20. Racial, ethnic, and socioeconomic disparities impact post-liver transplant survival in patients with hepatocellular carcinoma.
Huang DC; Yu RL; Alqahtani S; Tamim H; Saberi B; Bonder A
Ann Hepatol; 2023; 28(5):101127. PubMed ID: 37286167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]